Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Phase III study of canakinumab in systemic juvenile idiopathic arthritis completed

Nov. 21, 2011

Phase II data reported for S*BIO's SB-939

Nov. 21, 2011

Promising preclinical results presented for LDK-378

Nov. 18, 2011

Protein linked to prognosis of adenocarcinomas of the lung

Nov. 18, 2011

EZN-3042 administered with docetaxel in phase I study

Nov. 18, 2011

Anti-alpha-V/beta-6 antibody inhibits liver fibrosis

Nov. 18, 2011

ONO-2952 emerges as a potential treatment for stress-related disorders

Nov. 18, 2011

Favorable preclinical profile of C-21191 supports development for pain, spasticity

Nov. 17, 2011

EB-1020 as a new approach to treat ADHD

Nov. 17, 2011

Achillion Pharmaceuticals describes second-generation NS5A inhibitors

Nov. 17, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 3, 2026